Semler Scientific (NASDAQ:SMLR - Get Free Report) is projected to announce its Q2 2025 earnings results after the market closes on Monday, August 4th. Analysts expect the company to announce earnings of ($0.27) per share and revenue of $8.10 million for the quarter.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%. The firm had revenue of $8.84 million during the quarter.
Semler Scientific Price Performance
SMLR stock traded up $0.19 during midday trading on Thursday, hitting $36.10. The company's stock had a trading volume of 268,083 shares, compared to its average volume of 694,919. Semler Scientific has a 12 month low of $21.77 and a 12 month high of $81.56. The company has a quick ratio of 0.51, a current ratio of 0.52 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $497.83 million, a price-to-earnings ratio of -13.84 and a beta of 1.39. The company has a 50 day moving average of $38.58 and a two-hundred day moving average of $40.54.
Institutional Trading of Semler Scientific
Institutional investors have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Semler Scientific by 47.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,965 shares of the company's stock worth $144,000 after buying an additional 1,269 shares during the last quarter. AQR Capital Management LLC increased its stake in Semler Scientific by 71.7% in the first quarter. AQR Capital Management LLC now owns 15,251 shares of the company's stock worth $552,000 after purchasing an additional 6,371 shares during the period. Finally, Royal Bank of Canada increased its stake in Semler Scientific by 101.2% in the first quarter. Royal Bank of Canada now owns 43,977 shares of the company's stock worth $1,592,000 after purchasing an additional 22,123 shares during the period. 49.37% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several research analysts have weighed in on the company. Wall Street Zen downgraded Semler Scientific from a "buy" rating to a "sell" rating in a research note on Thursday, May 22nd. Maxim Group upgraded Semler Scientific to a "strong-buy" rating and set a $95.00 target price for the company in a research report on Wednesday, July 9th. Benchmark assumed coverage on Semler Scientific in a research report on Tuesday, July 8th. They set a "buy" rating and a $101.00 target price for the company. Finally, Cantor Fitzgerald assumed coverage on Semler Scientific in a research report on Monday. They set an "overweight" rating and a $61.00 target price for the company. One equities research analyst has rated the stock with a sell rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $82.00.
Read Our Latest Stock Report on Semler Scientific
Semler Scientific Company Profile
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Read More
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
